Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina

Gene Therapy

Volumn 10, Issue 16, 2003, Pages 1336-1344

  Bainbridge, J W B ^a   Mistry, A ^b   Schlichtenbrede, F C ^a   Smith, A ^a   Broderick, C ^a   De Alwis, M ^b   Georgiadis, A ^b   Taylor, P M ^c   Squires, M ^c   Sethi, C ^a   Charteris, D ^a   Thrasher, A J ^b   Sargan, D ^c   Ali, R R ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Canine; Gene therapy; rAAV; Retina

Indexed keywords

GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR; PROTEIN ANTIBODY; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CILIARY DISK; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOG; ELECTRORETINOGRAPHY; EYE INFLAMMATION; GENE EXPRESSION; GENETIC TRANSDUCTION; IMMUNE RESPONSE; NONHUMAN; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REPORTER GENE; RETINA CELL; RETINA CONE; RETINA DISEASE; RETINA ROD; RETINOTOMY; SURGICAL TECHNIQUE; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; VITRECTOMY;

ANIMALS; CELLS, CULTURED; DEPENDOVIRUS; DOGS; ELECTRORETINOGRAPHY; FUNDUS OCULI; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; INFLAMMATION; LUMINESCENT PROTEINS; PHOTORECEPTORS, VERTEBRATE; PIGMENT EPITHELIUM OF EYE; RETINAL DISEASES; TIME FACTORS; TRANSDUCTION, GENETIC;

ADENO-ASSOCIATED VIRUS; ANIMALIA; CANIS FAMILIARIS; CYTOMEGALOVIRUS; DNA VIRUSES; FELIDAE; PARVOVIRUS; RODENTIA;

EID: 0038253683     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301990     Document Type: Article

References (25)

1. Bessant DA, Ali RR, Bhattacharya SS. Molecular genetics and prospects for therapy of the inherited retinal dystrophies. Curr Opin Genet Dev 2001; 11: 307-316.
2. Rahmani B et al. The cause-specific prevalence of visual impairment in an urban population. The Baltimore Eye Survey. Ophthalmology 1996; 103: 1721-1726.
3. Bressler NM, Bressler SB. Preventative ophthalmology Age-related macular degeneration. Ophthalmology 1995; 102: 1206-1211.
4. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 1991; 98: 766-785.
5. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. [see comments]. Arch Ophthalmol 1991; 109: 1220-1231.
6. Ali RR et al. Gene transfer into the mouse retina mediated by an adeno-associated viral vector. Hum Mol Genet 1996; 5: 591-4.
7. Bennett J, Duan D, Engelhardt JF, Maguire AM. Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction. Invest Ophthalmol Vis Sci 1997; 38: 2857-2863.
8. Ali RR et al. Adeno-associated virus gene transfer to mouse retina. Hum Gene Therapy 1998; 9: 81-86.
9. Sarra GM et al. Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina. Hum Mol Genet 2001; 10: 2353-2361.
10. Bennett J et al. Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl Acad Sci USA 1999; 96: 9920-9925.
11. Ali RR et al. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat Genet 2000; 25: 306-310.
12. Bainbridge JW et al. Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1. Gene Therapy 2002; 9: 320-326.
13. Mori K et al. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci 2002; 43: 1994-2000.
14. Lai YK et al. Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy. Gene Ther 2002; 9: 804-813.
15. Dudus L et al. Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV. Vision Res 1999; 39: 2545-2553.
16. Acland GM et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet 2001; 28: 92-95.
17. Bennett J, Anand V, Acland GM, Maguire AM. Cross-species comparison of in vivo reporter gene expression after recombinant adeno-associated virus-mediated retinal transduction. Methods Enzymol 2000; 316: 777-789.
18. Zhang X et al. High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H. Hum Gene Ther 1999; 10: 2527-2537.
19. Conway JE et al. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap. Gene Therapy 1999; 6: 986-993.
20. Blanks JC, Johnson LV. Specific binding of peanut lectin to a class of retinal photoreceptor cells. A species comparison. Invest Ophthalmol Vis Sci 1984; 25: 546-557.
21. Greiner JV, Weidman TA. Histogenesis of the ferret retina. Exp Eye Res 1981; 33: 315-332.
22. Lotery AJ et al. Gene transfer to the nonhuman primate retina with recombinant feline immunodeficiency virus vectors. Hum Gene Ther 2002; 13: 689-696.
23. Imai K, Loewenstein A, de Juan Jr E. Translocation of the retina for management of subfoveal choroidal neovascularization I: experimental studies in the rabbit eye. Am J Ophthalmol 1998; 125: 627-634.
24. Terasaki H et al. Change in full-field ERGs after macular translocation surgery with 360 degrees retinotomy. Invest Ophthalmol Vis Sci 2002; 43: 452-457.
25. Luke C et al. Electrophysiological changes after 360 degrees retinotomy and macular translocation for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol 2001; 85: 928-932.